{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:00:08Z","timestamp":1792803608712,"version":"4.5.0"},"reference-count":90,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2019,3,28]]},"abstract":"<jats:sec><jats:title\/><jats:p>Malaria is a potentially life-threatening disease, affecting approx. 214 million people worldwide. Malaria is caused by a protozoan, Plasmodium falciparum, which is transmitted through the Anopheles mosquito. Malaria treatment is becoming more challenging due to rising resistance against the antimalarial drug, chloroquine. Novel compounds that target aspects of parasite development are being explored in attempts to overcome this wide-spread problem. Anti-malarial drugs target specific aspects of parasite growth and development within the human host. One of the most effective targets is the inhibition of hematin formation, either through inhibition of cysteine proteases or through iron chelation. Metal-thiosemicarbazone (TSC) complexes have been tested for antimalarial efficacy against drug-sensitive and drug-resistant strains of P. falciparum. An array of TSC complexes with numerous transition metals, including ruthenium, palladium, and gold has displayed antiplasmodial activity. Au(I)- and Pd(II)-TSC complexes displayed the greatest potency; 4-amino-7-chloroquine moieties were also found to improve antiplasmodial activity of TSCs. Although promising metal-TSC drug candidates have been tested against laboratory strains of P. falciparum, problems arise when attempting to compare between studies. Future work should strive to completely characterize synthesized metal-TSC structures and assess antiplasmodial potency against several drug-sensitive and drugresistant strains. Future studies need to precisely determine IC50 values for antimalarial drugs, chloroquine and ferroquine, to establish accurate standard values. This will make future comparisons across studies more feasible and potentially help reveal structure-function relationships. Investigations that attempt to link drug structures or properties to antiplasmodial mechanism(s) of action will aid in the design of antimalarial drugs that may combat rising drug resistance.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557518666181015152657","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:08:13Z","timestamp":1539691693000},"page":"569-590","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["A Structural Chemistry Perspective on the Antimalarial Properties of Thiosemicarbazone Metal Complexes"],"prefix":"10.2174","volume":"19","author":[{"given":"Kelly L.","family":"Summers","sequence":"first","affiliation":[{"name":"Department of Chemistry, College of Arts and Science, University of Saskatchewan, Saskatoon, SK S7N 5C9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.micro.091208.073403","volume":"63","author":"Aly A.S.I.","year":"2009","unstructured":"Aly ASI, Vaughan AM, Kappe SHI. Annu Rev Microbiol, Malaria parasite development in the mosquito and infection of the mammalian host.,, 2009, 63,, 195-221,","journal-title":"Annu Rev Microbiol"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2006.02.006","volume":"124","author":"Cowman A.F.","year":"2006","unstructured":"Cowman AF, Crabb BS. Cell, Invasion of red blood cells by malaria parasites.,, 2006, 124,, 755-766,","journal-title":"Cell"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijpara.2008.09.007","volume":"39","author":"Gilson P.R.","year":"2009","unstructured":"Gilson PR, Crabb BS. Int J Parasitol, Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites.,, 2009, 39,, 91-96,","journal-title":"Int J Parasitol"},{"key":"ref=4","author":"","year":"2015","unstructured":". , World Malaria Report , (accessed 14 December 2016)., 2015"},{"key":"ref=5","first-page":"1556","volume":"92","author":"Warhurst D.C.","year":"2007","unstructured":"Warhurst DC. Curr Sci, Understanding resistance to antimalarial 4-aminoquinolines, cinchona alkaloids and the highly hydrophobic arylaminoalcohols.,, 2007, 92,, 1556-1560,","journal-title":"Curr Sci"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijantimicag.2007.01.002","volume":"30","author":"Jana S.","year":"2007","unstructured":"Jana S, Paliwal J. Int J Antimicrob Agents, Novel molecular targets for antimalarial chemotherapy.,, 2007, 30,, 4-10,","journal-title":"Int J Antimicrob Agents"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2174\/092986707780090927","volume":"14","author":"Mital A.","year":"2007","unstructured":"Mital A. Curr Med Chem, Recent advances in antimalarial compounds and their patents.,, 2007, 14,, 759-773,","journal-title":"Curr Med Chem"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.1021\/jm900552r","volume":"52","author":"Yu Y.","year":"2009","unstructured":"Yu Y, Kalinowski DS, Kovacevic Z, Siafakas AR, Jansson PJ, Stefani C, Lovejoy DB, Sharpe PC, Bernhardt PV, Richardson DR. J Med Chem, Thiosemicarbazones from the old to new: Iron chelators that are more than just ribonucleotide reductase inhibitors.,, 2009, 52,, 5271-5294,","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2008.03.008","volume":"160","author":"Muller I.B.","year":"2008","unstructured":"Muller IB, Gupta RD, Luerson K, Wrenger C, Walter RD. Mol Biochem Parasitol, Assessing the polyamine metabolism of Plasmodium falciparum as chemotherapeutic target.,, 2008, 160,, 1-7,","journal-title":"Mol Biochem Parasitol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","volume":"298","author":"Sidhu A.B.S.","year":"2002","unstructured":"Sidhu ABS, Verdier-Pinard D, Fidock DA. Science, Chloroquine resistance in plasmodium falciparum malaria parasites conferred by pfcrt mutations.,, 2002, 298,, 210-213,","journal-title":"Science"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/molecules14082868","volume":"14","author":"De Villers K.A.","year":"2009","unstructured":"De Villers KA, Egan TJ. Molecules, Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis.,, 2009, 14,, 2868-2887,","journal-title":"Molecules"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0010-8545(99)00112-5","volume":"190-192","author":"Egan T.J.","year":"1999","unstructured":"Egan TJ, Marques HM. Coord Chem Rev, The role of haem in the activity of chloroquine and related antimalarial drugs.,, 1999, 190-192,, 493-517,","journal-title":"Coord Chem Rev"},{"key":"ref=13","first-page":"A244","author":"Nagel R.L.","year":"1991","unstructured":"Nagel RL, Traore O, Carnevale P, Kaptuenoche L, Elion J, Labie D. Clin Res, In Pilot-study of the use of desferrioxamine in the treatment of Plasmodium-falciparum malaria.,, 1991, 190-192,, A244-A244,","journal-title":"Clin Res"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.2830370316","volume":"37","author":"Traore O.","year":"1991","unstructured":"Traore O, Carnevale P, Kaptuenoche L, Mbede J, Desfontaine M, Elion J, Labie D, Nagel RL. Am J Hematol, Preliminary-report on the use of desferrioxamine in the treatment of Plasmodium-falciparum malaria.,, 1991, 37,, 206-208,","journal-title":"Am J Hematol"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.2830410117","volume":"41","author":"Gangarossa S.","year":"1992","unstructured":"Gangarossa S, Schiliro G, Russo R. Am J Hematol, Desferrioxamine in the treatment of Plasmodium falciparum malaria.,, 1992, 41,, 67-,","journal-title":"Am J Hematol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jinorgbio.2013.08.007","volume":"129","author":"Walcourt A.","year":"2013","unstructured":"Walcourt A, Kuranstin-Mills J, Kwagyan J, Adenuga BB, Kalinowski D, Lovejoy DB, Lane DJR, Richardson DR. J Inorg Biochem, Antiplasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: Effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.,, 2013, 129,, 43-51,","journal-title":"J Inorg Biochem"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1073\/pnas.90.20.9280","volume":"90","author":"Rubin H.","year":"1993","unstructured":"Rubin H, Salem JS, Li L-S, Yang F-D, Mama S, Wang Z-M, Fisher A, Hamann CS, Cooperman BS. Proc Acad Nat Sci USA, Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: A target for antimalarial therapy.,, 1993, 90,, 9280-9284,","journal-title":"Proc Acad Nat Sci USA"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ccr.2008.07.004","volume":"253","author":"Lobana T.S.","year":"2009","unstructured":"Lobana TS, Sharma R, Bawa G, Khanna S. Coord Chem Rev, Bonding and structure trends of thiosemicarbazone derivatives of metals\u2014An overview.,, 2009, 253,, 977-1055,","journal-title":"Coord Chem Rev"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jorganchem.2013.02.024","volume":"736","author":"Adams M.","year":"2013","unstructured":"Adams M, De Kock C, Smith PJ, Chibale K, Smith GS. J Organomet Chem, Synthesis, characterization and antiplasmodial evaluation of cyclopalladated thiosemicarbazone complexes.,, 2013, 736,, 19-26,","journal-title":"J Organomet Chem"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1021\/jm030549j","volume":"47","author":"Greenbaum D.C.","year":"2004","unstructured":"Greenbaum DC, Mackey Z, Hansell E, Doyle P, Gut J, Caffrey CR, Lehrman J, Rosenthal PJ, Mckerrow JH, Chibale K. J Med Chem, Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.,, 2004, 47,, 3212-3219,","journal-title":"J Med Chem"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jorganchem.2010.06.010","volume":"695","author":"Chellan P.","year":"2010","unstructured":"Chellan P, Naser S, Vivas L, Chibale K, Smith GS. J Organomet Chem, Cyclopalladated complexes containing tridentate thiosemicarbazone ligands of biological significance: Synthesis, structure and antimalarial activity.,, 2010, 695,, 2225-2232,","journal-title":"J Organomet Chem"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2174\/138955709789957422","volume":"9","author":"Matesanz A.I.","year":"2009","unstructured":"Matesanz AI, Souza P. Mini Rev Med Chem, \u03b1-N-Heterocyclic thiosemicarbazone derivatives as potential antitumor agents: A structure-activity relationships approach.,, 2009, 9,, 1389-1396,","journal-title":"Mini Rev Med Chem"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1574892811308020005","volume":"8","author":"Moorthy N.S.H.N.","year":"2013","unstructured":"Moorthy NSHN, Cerqueira NMFSA, Ramos MJ, Fernandes PA. Recent Patents Anticancer Drug Discov, Aryl- and Heteroaryl-Thiosemicarbazone derivatives and their metal complexes: A pharmacological template.,, 2013, 8,, 1-14,","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"ref=24","author":"Vieira R.P.","unstructured":"Vieira RP, Beraldo H, , John Wiley and Sons, Ltd.,Design of Schiff Base-derived ligands: Applications in therapeutics and medical diagnosis., Chichester, UK, , In Ligand Design in Medicinal Inorganic Chemistry., 2014,-","journal-title":"In Ligand Design in Medicinal Inorganic Chemistry"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0010-8545(93)85052-6","volume":"123","author":"West D.X.","year":"1993","unstructured":"West DX, Liberta AE, Padhye SB, Chikate RC, Sonawane PB, Kumbhar AS, Yerande RG. Coord Chem Rev, Thiosemicarbazone complexes of copper(I1): structural and biological studies.,, 1993, 123,, 49-71,","journal-title":"Coord Chem Rev"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/ar300074t","volume":"45","author":"Crouch P.J.","year":"2012","unstructured":"Crouch PJ, Barnham KJ. Acc Chem Res, Therapeutic redistribution of metal ions to treat Alzheimer\u2019s disease.,, 2012, 45,, 1604-1611,","journal-title":"Acc Chem Res"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.2174\/1568026616666160216155746","volume":"16","author":"Mckenzie-Nickson S.","year":"2016","unstructured":"Mckenzie-Nickson S, Bush AI, Barnham KJ. Curr Top Med Chem, Bis(thiosemicarbazone) metal complexes as therapeutics for neurodegenerative diseases.,, 2016, 16,, 3058-3068,","journal-title":"Curr Top Med Chem"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1039\/c0cs00215a","volume":"40","author":"Paterson B.M.","year":"2011","unstructured":"Paterson BM, Donnelly PS. Chem Soc Rev, Copper complexes of bis(thiosemicarbazones): From chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals.,, 2011, 40,, 3005-3018,","journal-title":"Chem Soc Rev"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1517\/13543776.16.11.1533","volume":"16","author":"Birch N.","year":"2006","unstructured":"Birch N, Wang X, Chong H-S. Expert Opin Ther Pat, Iron chelators as therapeutic iron depletion agents.,, 2006, 16,, 1533-1556,","journal-title":"Expert Opin Ther Pat"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/med.20163","volume":"30","author":"Ettari R.","year":"2010","unstructured":"Ettari R, Bova F, Zappala M, Grasso S, Micale N. Med Res Rev, Falcipain-2 Inhibitors.,, 2010, 30,, 136-167,","journal-title":"Med Res Rev"},{"key":"ref=31","first-page":"20","volume":"61","author":"Mertens A.","year":"1950","unstructured":"Mertens A, Bunge R. Am Rev Tuberc, The present status of the chemotherapy of tuberculosis with conteben, a substance of the thiosemicarbazone series - A review.,, 1950, 61,, 20-38,","journal-title":"Am Rev Tuberc"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2015.07.009","volume":"101","author":"Wani W.A.","year":"2015","unstructured":"Wani WA, Jameel E, Baig U, Mumtazuddin S, Hun LT. Eur J Med Chem, Ferroquine and its derivatives: New generation of antimalarial agents.,, 2015, 101,, 534-551,","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/03602530903178905","volume":"41","author":"Weinberg E.D.","year":"2009","unstructured":"Weinberg ED, Moon J. Drug Metab Rev, Malaria and iron: History and review.,, 2009, 41,, 644-662,","journal-title":"Drug Metab Rev"},{"key":"ref=34","author":"Dehdashti F.","year":"2010","unstructured":"Dehdashti F. , . Phase II Trial of 64Cu-ATSM PET\/CT in Cervical Cancer. (NCT00794339 or ACRIN-6682);, , 2010"},{"key":"ref=35","author":"Beckman J.","unstructured":", Beckman J. blogs.oregonstate.edu\/linuspaulinginstitute\/2016\/ 02\/03\/als-patients-cuatsm-clinical-trials\/, Summary for ALS Patients about CuATSM and Clinical Trials, ,2016","journal-title":"Summary for ALS Patients about CuATSM and Clinical Trials"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2016.01.020","volume":"89","author":"Williams J.R.","year":"2016","unstructured":"Williams JR, Trias E, Beilby PR, Lopez NI, Labut EM, Bradford CS, Roberts BR, Mcallum EJ, Crouch PJ, Rhoads TW, Pereira C, Son M, Elliot JL, Franco MC, Est\u00e9vez AG, Barbeito L, Beckman JS. Neurobiol Dis, Copper delivery to the CNS by CuATSM effectively treats motor neuron disease in SODG93A mice co-expressing the Copper-Chaperone-for-SOD.,, 2016, 89,, 1-9,","journal-title":"Neurobiol Dis"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0010-8545(00)00363-5","volume":"209","author":"Casas J.S.","year":"2000","unstructured":"Casas JS, Garcia-Tasende MS, Sordo J. Coord Chem Rev, Main group metal complexes of semicarbazones and thiosemicarbazones. A structural review.,, 2000, 209,, 197-261,","journal-title":"Coord Chem Rev"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1389557043487484","volume":"4","author":"Beraldo H.","year":"2004","unstructured":"Beraldo H, Gambino D. Mini Rev Med Chem, The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes.,, 2004, 4,, 31-39,","journal-title":"Mini Rev Med Chem"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1039\/C4DT00022F","volume":"43","author":"Glisic B.D.","year":"2014","unstructured":"Glisic BD, Djuran MI. Dalton Trans, Gold complexes as antimicrobial agents: An overview of different biological activities in relation to the oxidation state of the gold ion and the ligand structure.,, 2014, 43,, 5950-5970,","journal-title":"Dalton Trans"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1080\/15533174.2015.1004463","volume":"46","author":"Nasser A.M.","year":"2016","unstructured":"Nasser AM. Synth React Inorg Met-Org Chem, Bioactive palladium azomethine chelates, a review of recent research.,, 2016, 46,, 1349-1366,","journal-title":"Synth React Inorg Met-Org Chem"},{"key":"ref=41","first-page":"16","volume":"3","author":"Pelosi G.","year":"2010","unstructured":"Pelosi G. , Thiosemicarbazone metal complexes: From structure to activity. Open Crystallograph.j, , 2010"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.14233\/ajchem.2013.OH105","volume":"25","author":"Shim J.","year":"2013","unstructured":"Shim J, Jyothi NR, Farook NM. Asian J Chem, Biological applications of thiosemicarbazones and their metal complexes.,, 2013, 25,, 5838-5840,","journal-title":"Asian J Chem"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2174\/0929867033456963","volume":"10","author":"Chibale K.","year":"2003","unstructured":"Chibale K, Musonda CC. Curr Med Chem, The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors.,, 2003, 10,, 1863-1889,","journal-title":"Curr Med Chem"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jorganchem.2013.04.017","volume":"739","author":"Adams M.","year":"2013","unstructured":"Adams M, De Kock C, Smith PJ, Malatji P, Hutton AT, Chibale K, Smith GS. J Organomet Chem, Heterobimetallic ferrocenylthiosemicarbazone palladium(II) complexes: Synthesis, electrochemistry and antiplasmodial evaluation.,, 2013, 739,, 15-20,","journal-title":"J Organomet Chem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.bmcl.2007.10.003","volume":"17","author":"Biot C.","year":"2007","unstructured":"Biot C, Pradines B, Sergeant M-H, Gut J, Rosenthal PJ, Chibale K. Bioorg Med Chem Lett, Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues.,, 2007, 17,, 6436-6438,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1039\/c3dt32740j","volume":"42","author":"Adams M.","year":"2013","unstructured":"Adams M, Li Y, Khot H, De Kock C, Smith PJ, Land KM, Chibale K, Smith GS. Dalton Trans, The synthesis and antiparasitic activity of aryl- and ferrocenyl-derived thiosemicarbazone ruthenium(II)\u2013arene complexes.,, 2013, 42,, 4677-4685,","journal-title":"Dalton Trans"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jorganchem.2016.06.032","volume":"819","author":"Baartzes N.","year":"2016","unstructured":"Baartzes N, Stringer T, Okombo J, Seldon R, Warner DF, De Kock C, Smith PJ, Smith GS. J Organomet Chem, Mono- and polynuclear ferrocenylthiosemicarbazones: Synthesis, characterisation and antimicrobial evaluation.,, 2016, 819,, 166-172,","journal-title":"J Organomet Chem"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1080\/00958970500213307","volume":"58","author":"Costa R.F.F.","year":"2006","unstructured":"Costa RFF, Rebolledo AP, Matencio T, Calado HDR, Ardisson JD, Cortes ME, Rodrigues BL, Beraldo H. J Coord Chem, Metal complexes of 2-benzoylpyridine semicarbazone: spectral, electrochemical and structural studies.,, 2006, 58,, 1307-1319,","journal-title":"J Coord Chem"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1016\/j.jorganchem.2011.07.028","volume":"696","author":"Khanye S.D.","year":"2011","unstructured":"Khanye SD, Gut J, Rosenthal PJ, Chibale K, Smith GS. J Organomet Chem, Ferrocenylthiosemicarbazones conjugated to a poly(propyleneimine) dendrimer scaffold: Synthesis and in vitro antimalarial activity.,, 2011, 696,, 3296-3300,","journal-title":"J Organomet Chem"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1158\/1535-7163.MCT-05-0384","volume":"5","author":"Shao J.","year":"2006","unstructured":"Shao J, Zhou B, Dibilio AJ, Zhu L, Wang T, Qi C, Shih J, Yen Y. Mol Cancer Ther, A Ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase.,, 2006, 5,, 586-592,","journal-title":"Mol Cancer Ther"},{"key":"ref=51","first-page":"36","author":"Walcourt A.","year":"2004","unstructured":"Walcourt A, Loyevsky M, Lovejoy DB, Gordeuk VR, Richardson DR. Int J Biochem Cell Biol, Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites.,, 2004, 5,, 36-,","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1155\/BCA.2005.271","volume":"3","author":"Agrawal R.K.","year":"2005","unstructured":"Agrawal RK, Prasad S. Bioinorg Chem Appl, Synthesis, spectroscopic and physiochemical characterization and biological activity of Co(II) and Ni(II) coordination compounds with 4-aminoantipyrine thiosemicarbazone.,, 2005, 3,, 271-288,","journal-title":"Bioinorg Chem Appl"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1016\/j.bmc.2010.07.039","volume":"18","author":"Bahl D.","year":"2010","unstructured":"Bahl D, Athar F, Soares MBP, De Sa MS, Moreira DRM, Srivastava RM, Leite ACL, Azam A. Bioorg Med Chem Lett, Structure-activity relationships of mononuclear metal-thiosemicarbazone complexes endowed with potent antiplasmodial and antiamoebic activities.,, 2010, 18,, 6857-6864,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1039\/C5DT04918K","volume":"45","author":"Adams M.","year":"2016","unstructured":"Adams M, Barnard L, De Kock C, Smith PJ, Wiesner L, Chibale K, Smith GS. Dalton Trans, Cyclopalladated organosilane\u2013tethered thiosemicarbazones: novel strategies for improving antiplasmodial activity.,, 2016, 45,, 5514-5520,","journal-title":"Dalton Trans"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1039\/C4DT03234A","volume":"44","author":"Adams M.","year":"2015","unstructured":"Adams M, De Kock C, Smith PJ, Land KM, Liu N, Hopper M, Hsiao A, Burgoyne AR, Stringer T, Meyer M, Wiesner L, Chibale K, Smith GS. Dalton Trans, Improved antiparasitic activity by incorporation of organosilane entities into half-sandwich ruthenium(II) and rhodium(III) thiosemicarbazone complexes.,, 2015, 44,, 2456-2468,","journal-title":"Dalton Trans"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jccs.201200301","volume":"60","author":"Anchuri S.S.","year":"2013","unstructured":"Anchuri SS, Dhulipala S, Thota S, Bongoni RN, Yerra R, Reddy ARN. J Chin Chem Soc, Antimicrobial and antimalarial activity of novel synthetic mononuclear ruthenium(II) compounds.,, 2013, 60,, 153-159,","journal-title":"J Chin Chem Soc"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1002\/ejic.201000317","volume":"2010","author":"Chellan P.","year":"2010","unstructured":"Chellan P, Shunmoogam-Gounden N, Hendricks DT, Gut J, Rosenthal PJ, Lategan C, Smith PJ, Chibale K, Smith GS. Eur J Inorg Chem, Synthesis, structure and in vitro biological screening of palladium(II) complexes of functionalised salicylaldimine thiosemicarbazones as antimalarial and anticancer agents.,, 2010, 2010,, 3520-3528,","journal-title":"Eur J Inorg Chem"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.1021\/om300334z","volume":"31","author":"Chellan P.","year":"2012","unstructured":"Chellan P, Land KM, Shokar A, Au A, An SH, Clavel CM, Dyson PJ, De Kock C, Smith PJ, Chibale K, Smith GS. Organometallics, Exploring the versatility of cycloplatinated thiosemicarbazones as antitumor and antiparasitic agents.,, 2012, 31,, 5791-5799,","journal-title":"Organometallics"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1039\/b925037a","volume":"39","author":"Khanye S.D.","year":"2010","unstructured":"Khanye SD, Bathori NB, Smith GS, Chibale K. Dalton Trans, Gold(I) derived thiosemicarbazone complexes with rare halogen\u2013halogen interaction\u2013reduction of [Au(damp-C1,N)Cl].,, 2010, 39,, 2697-2700,","journal-title":"Dalton Trans"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jinorgbio.2010.06.005","volume":"104","author":"Khanye S.D.","year":"2010","unstructured":"Khanye SD, Smith GS, Lategan C, Smith PJ, Gut J, Rosenthal PJ, Chibale K. J Inorg Biochem, Synthesis and in vitro evaluation of gold(I) thiosemicarbazone complexes for antimalarial activity.,, 2010, 104,, 1079-1083,","journal-title":"J Inorg Biochem"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.jorganchem.2011.07.026","volume":"696","author":"Khanye S.D.","year":"2011","unstructured":"Khanye SD, Wan B, Franzhlau SG, Gut J, Rosenthal PJ, Smith GS, Chibale K. J Organomet Chem, Synthesis and in vitro antimalarial and antitubercular activity of gold(III) complexes containing thiosemicarbazone ligands.,, 2011, 696,, 3392-3396,","journal-title":"J Organomet Chem"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1039\/c1dt10885a","volume":"40","author":"Molter A.","year":"2011","unstructured":"Molter A, Rust J, Lehmann CW, Deepa G, Chiba P, Mohr F. Dalton Trans, Synthesis, structures and anti-malaria activity of some gold(I) phosphine complexes containing seleno- and thiosemicarbazonato ligands.,, 2011, 40,, 9810-9820,","journal-title":"Dalton Trans"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1021\/jm049792o","volume":"47","author":"Navarro M.","year":"2004","unstructured":"Navarro M, Vasquez F, Sanchez-Delgado RA, Perez H, Sinou V, Schrevel J. J Med Chem, Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes.,, 2004, 47,, 5204-5209,","journal-title":"J Med Chem"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bmc.2006.09.055","volume":"15","author":"Chipeleme A.","year":"2007","unstructured":"Chipeleme A, Gut J, Rosenthal PJ, Chibale K. Bioorg Med Chem Lett, Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum.,, 2007, 15,, 273-282,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/073911011010524993","volume":"29","author":"Lo Y-C.","year":"2011","unstructured":"Lo Y-C, Su W-C, Ko T-P, Wang N-C, Wang AH-J. J Biomol Struct Dyn, Terpyridine platinum(II) complexes inhibit cysteine proteases by binding to active-site cysteine.,, 2011, 29,, 267-282,","journal-title":"J Biomol Struct Dyn"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0006-2952(03)00338-1","volume":"66","author":"Sweeney D.","year":"2003","unstructured":"Sweeney D, Raymera ML, Lockwood TD. Biochem Pharmacol, Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.,, 2003, 66,, 663-677,","journal-title":"Biochem Pharmacol"},{"key":"ref=67","first-page":"193","volume":"56","author":"Bailey-Wood R.","year":"1975","unstructured":"Bailey-Wood R, Blayney L, Anjuir JR, Jacobs A. Br J Exp Pathol, The effects of iron deficiency on rat liver enzymes.,, 1975, 56,, 193-198,","journal-title":"Br J Exp Pathol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jmgm.2009.03.001","volume":"28","author":"Trossini G.H.G.","year":"2009","unstructured":"Trossini GHG, Guido RVC, Oliva G, Ferreira EI, Andricopulo AD. J Mol Graph Model, Quantitative structure\u2013activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: Molecular modeling, CoMFA and CoMSIA studies.,, 2009, 28,, 3-11,","journal-title":"J Mol Graph Model"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-8545(02)00100-5","volume":"232","author":"Farrel N.","year":"2002","unstructured":"Farrel N. Coord Chem Rev, Biomedical uses and applications of inorganic chemistry. An overview.,, 2002, 232,, 1-4,","journal-title":"Coord Chem Rev"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1021\/jm00281a015","volume":"15","author":"Agrawal K.C.","year":"1972","unstructured":"Agrawal KC, Booth BA, Moore EC, Santorelli A. J Med Chem, Potential antitumor agents. 6. Possible irreversible inhibitors of ribonucleoside diphosphate reductase.,, 1972, 15,, 1154-1158,","journal-title":"J Med Chem"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0748-5514(85)90147-3","volume":"1","author":"Ames J.R.","year":"1985","unstructured":"Ames JR, Ryan MD, Klayman DL, Kovacic P. J Free Radic Biol Med, Charge transfer and oxy radicals in antimalarial action. Quinones, dapsone metabolites, metal complexes, iminium ions, and peroxides.,, 1985, 1,, 353-361,","journal-title":"J Free Radic Biol Med"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/jm801012z","volume":"52","author":"Bernhardt P.V.","year":"2009","unstructured":"Bernhardt PV, Sharpe PC, Islam M, Lovejoy DB, Kalinowski DS, Richardson DR. J Med Chem, Iron chelators of the dipyridylketone thiosemicarbazone class: Precomplexation and transmetalation effects on anticancer activity.,, 2009, 52,, 407-415,","journal-title":"J Med Chem"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1021\/cg025550i","volume":"2","author":"Buller R.","year":"2002","unstructured":"Buller R, Peterson ML, Almarsson O, Leiserowitz L. Cryst Growth Des, Quinoline binding site on malaria pigment crystal: A rational pathway for antimalaria drug design.,, 2002, 2,, 553-562,","journal-title":"Cryst Growth Des"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejmech.2013.08.004","volume":"69","author":"Stringer T.","year":"2013","unstructured":"Stringer T, Taylor D, De Kock C, Guzgay H, Au A, An SH, Sanchez B, O\u2019connor R, Patel N, Land KM, Smith PJ, Hendricks DT, Egan TJ, Smith GS. Eur J Med Chem, Synthesis, characterization, antiparasitic and cytotoxic evaluation of thioureas conjugated to polyamine scaffolds.,, 2013, 69,, 90-98,","journal-title":"Eur J Med Chem"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10895-013-1285-8","volume":"24","author":"Cui F.L.","year":"2014","unstructured":"Cui FL, Liu QF, Luo HX, Zhang GS. J Fluoresc, Spectroscopic, Viscositic and Molecular Modeling Studies on the Interaction of 3 '-Azido-Daunorubicin Thiosemicarbazone with DNA.,, 2014, 24,, 189-195,","journal-title":"J Fluoresc"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1080\/00958972.2013.867030","volume":"66","author":"Fan X.R.","year":"2013","unstructured":"Fan XR, Dong JJ, Min R, Chen Y, Yi XY, Zhou JL, Zhang SC. J Coord Chem, Cobalt(II) complexes with thiosemicarbazone as potential antitumor agents: synthesis, crystal structures, DNA interactions, and cytotoxicity.,, 2013, 66,, 4268-4279,","journal-title":"J Coord Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0162-0134(99)00105-1","volume":"76","author":"Matesanz A.I.","year":"1999","unstructured":"Matesanz AI, Perez JM, Navarro P, Moreno JM, Colacio E, Souza P. J Inorg Biochem, Synthesis and characterization of novel palladium(II) complexes of bis(thiosemicarbazone). Structure, cytotoxic activity and DNA binding of Pd(II)-benzyl bis(thiosemicarbazonate).,, 1999, 76,, 29-37,","journal-title":"J Inorg Biochem"},{"key":"ref=78","first-page":"1771","volume":"30","author":"Min R.","year":"2014","unstructured":"Min R, Fan XR, Zhou P, Yan J, Zhou JL, Zhang SC. Chin J Inorg Chem,, Synthesis, Crystal Structure, DNA Interaction and Antitumor Activity of Nickel(II) Complex with Quinoline-2-carboxaldehyde N-4-methyl-thiosemicarbazone.,, 2014, 30,, 1771-1777,","journal-title":"Chin J Inorg Chem,"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ica.2013.09.014","volume":"408","author":"Palanimuthu D.","year":"2013","unstructured":"Palanimuthu D, Samuelson AG. Inorg Chim Acta, Dinuclear zinc bis(thiosemicarbazone) complexes: Synthesis, in vitro anticancer activity, cellular uptake and DNA interaction study.,, 2013, 408,, 152-161,","journal-title":"Inorg Chim Acta"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/(SICI)1099-0739(199812)12:12<809::AID-AOC754>3.0.CO;2-X","volume":"12","author":"Quiroga A.G.","year":"1998","unstructured":"Quiroga AG, Perez JM, Alonso C, Navarro-Ranninger C. Appl Organomet Chem, DNA binding and in vitro antileukemic activity of dimeric and tetrameric platinated complexes derived from p-isopropyl-benzaldehyde thiosemicarbazone.,, 1998, 12,, 809-813,","journal-title":"Appl Organomet Chem"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.poly.2015.12.012","volume":"105","author":"Vikneswaran R.","year":"2016","unstructured":"Vikneswaran R, Eltayeb NE, Ramesh S, Yahya R. Polyhedron, New alicyclic thiosemicarbazone chelated zinc(II) antitumor complexes: Interactions with DNA\/protein, nuclease activity and inhibition of topoisomerase-I.,, 2016, 105,, 89-95,","journal-title":"Polyhedron"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.bmcl.2006.10.049","volume":"17","author":"Yang Z.Y.","year":"2007","unstructured":"Yang ZY, Wang Y, Wang Y. Bioorg Med Chem Lett, Study on synthesis, structure, and DNA-binding of lanthanide complexes with 2-carboxyl-benzaldiehyde thiosemicarbazone.,, 2007, 17,, 2096-2101,","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1021\/ic802220w","volume":"48","author":"Rajapakse C.S.K.","year":"2009","unstructured":"Rajapakse CSK, Martinez A, Naoulou B, Jarzecki AA, Suarez L, Deregnaucourt C, Sinou V, Schrevel J, Musi E, Ambrosini G, Schwartz GK, Sanchez-Delgado RA. Inorg Chem, Synthesis, characterization, and in vitro antimalarial and antitumour activity of new ruthenium(II) complexes of chloroquine.,, 2009, 48,, 1122-1131,","journal-title":"Inorg Chem"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/jm00352a036","volume":"25","author":"Scovill J.P.","year":"1982","unstructured":"Scovill JP, Klayman DL, Franchino CF. J Med Chem, 2-Acetylpyridine Thiosemicarbazones. 4. Complexes with Transition Metals as Antimalarial and Antileukemic Agents.,, 1982, 25,, 1261-1264,","journal-title":"J Med Chem"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/jm3010114","volume":"56","author":"Franz A.K.","year":"2012","unstructured":"Franz AK, Wilson SO. J Med Chem, Organosilicon Molecules with Medicinal Applications.,, 2012, 56,, 388-405,","journal-title":"J Med Chem"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp0500061","volume":"2","author":"Biot C.","year":"2005","unstructured":"Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ. Mol Pharm, Insights into the mechanism of action of ferroquine. relationship between physicochemical properties and antiplasmodial activity.,, 2005, 2,, 185-193,","journal-title":"Mol Pharm"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1128\/AAC.05359-11","volume":"56","author":"Supan C.","year":"2012","unstructured":"Supan C, Mombo-Ngoma G, Dal-Bianco M, Ospina Salazar CL, Mazuir F, Filali-Ansary A, Biot C, Ter-Minassian D, Ramharter M, Kremsner PG, Lell B. Antimicrob Agents Chemother, Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of plasmodium falciparum infections.,, 2012, 56,, 3165-3173,","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1021\/jm8006678","volume":"51","author":"Casini A.","year":"2008","unstructured":"Casini A, Gabbiani C, Sorrentino F, Rigobello MP, Bindoli A, Geldbach TJ, Marrone A, Re N, Hartinger CG, Dyson PJ, Messori L. J Med Chem, Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin b by antitumor ruthenium(II)\u2212arene compounds.,, 2008, 51,, 6773-6781,","journal-title":"J Med Chem"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/om300354x","volume":"31","author":"Herrmann C.","year":"2012","unstructured":"Herrmann C, Salas PF, Cawthray JF, De Kock C, Patrick BO, Smith PJ, Adam MJ, Orvig C. Organometallics, 1,1\u2032-Distributed ferrocenyl carbohydrate chloroquine conjugates as potential antimalarials.,, 2012, 31,, 5736-5747,","journal-title":"Organometallics"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1016\/j.bmcl.2007.10.003","volume":"17","author":"Biot C.","year":"2007","unstructured":"Biot C, Pradines B, Sergeant M-H, Gut J, Rosenthal PJ, Chibale K. Bioorg Med Chem Lett, Design, synthesis, and anti-malarial activity of structural chimeras of thiosemicarbazone ferroquine analogues.,, 2007, 17,, 6434-6438,","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/166273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T05:02:32Z","timestamp":1605243752000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/166273\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":90,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,3,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557518666181015152657","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}